NDC 0338-9545
clindamycin phosphate 300 mg per 50 mL injection, solution
On the label: Baxter Healthcare Corporation.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Baxter Healthcare Corporation | Round Lake, IL, United States | Makes it, tests it, packages it, labels it and sterilizes it | Serious problems, FDA actionApr 2, 2026 · 15 inspections, 2 with FDA action |
Recalls
- Aug 6, 2026 · Class II · Baxter Healthcare Corporation
CGMP Deviations
Lots: Lot # NC193689, Exp Date: 10/16/2027.
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Clindamycin: every company that makes it
- Form
- injection, solution, intravenous
- Strength
- 300 mg per 50 mL
- Approval
- NDA NDA208083
- On the market since
- Apr 20, 2017
- Package NDCs
0338-9545-240338-9545-50- Official label
- DailyMed (National Library of Medicine), updated Apr 28, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?